CLINICAL_TRIALS
trial_result
· 2019-04-03
Clinical Trial Update: Bupivacaine for Benign Headache in the ED [Phase 2]
Summary
Phase 2 trial evaluating bupivacaine for benign headache in the emergency department was terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Wake Forest University Health Sciences | Conditions: Benign Headache | Phase 2 | Status: TERMINATED | Results posted: 2019-04-03